Probiotics in Pregnancy pilot study
- Conditions
- anxiety, depression, pregnancy, probiotics
- Registration Number
- NL-OMON26403
- Lead Sponsor
- Behavioural Science Institute, Radboud University, Nijmegen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 40
1. Healthy pregnant women (>18 years) in obstetric care in the Netherlands with at least elevated symptoms of depression and/or anxiety (resp. EDS ≥ 10; STAI-S > 40)
2. Women who can start daily probiotic intake from ≥26 weeks gestational age until delivery (Gestation is based on last menstrual period and early ultrasound)
1) Multiple pregnancy (increased obstetric risk);
2) High suicidal risk according to suicidality subscale score on the MINI International Neuropsychiatric Interview;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is the number of successfully met<br>feasibility criteria linked to the intervention and study design.<br /><br>• feasibility of recruitment pathways (the ACCEPT checklist);<br /><br>• participant retention;<br /><br>• acceptability of study measures;<br /><br>• number of women in Wageningen region (the Netherlands) eligible for this pilot trial.
- Secondary Outcome Measures
Name Time Method Secondary outcomes include:<br /><br>• Quantitative data assessing mental health in mothers (anxiety, stress and depression);<br /><br>• Crying behaviour in children;<br /><br>• Biological data, including maternal cortisol, maternal vaginal microbiota, maternal intestinal microbiota<br>and intestinal microbial composition, and infant intestinal<br>microbial composition
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.